ArticleTranslational lung cancer research2020

Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)-a German radiation oncology survey.

Lukas Käsmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.